scorecardresearch
Add as a preferred source on Google
Monday, November 17, 2025
TopicCoronavirus

Topic: Coronavirus

Coronavirus or Covid-19 is an infectious disease caused by the SARS-CoV-2 virus. It is a viral disease that turned into a pandemic in early 2020. The first known case was recorded in Wuhan, China, in December 2019. Coronavirus has multiple variants such as Delta and Omicron, and its most common symptoms are fever, chills and sore throat.

India reports 10,126 new Covid cases in last 24 hours, lowest in 266 days

PTI -
While 332 deaths took place during the same period due to coronavirus, the national recovery rate was recorded at 98.25%, the highest since March 2020.

UK to add Covaxin to approved list of Covid vaccines from 22 Nov

PTI -
Those inoculated with the Bharat Biotech-manufactured shot will not have to self-isolate after arrival in England. The move follows WHO's Emergency Use Listing for Covaxin.

‘Cut Covishield gap, skies won’t fall’, says Covid task force member as vaccines pile up

Abantika Ghosh -
According to Dr Subhash Salunkhe, one reason for increasing Covishield dose gap was vaccine shortfall, says ‘there should be more latitude in this now that situation has eased’.

Zydus Cadila to supply 1 crore doses of ZyCoV-D vaccine to Modi govt at Rs 265 per jab

PTI -
The three-dose Covid vaccine was cleared by India’s drug regulator for inoculation of those aged 12 years and above.

India reports 11,451 new Covid cases, 266 deaths in last 24 hours

PTI -
The active cases declined to 1,42,826, the lowest in 262 days, while the national recovery rate was recorded at 98.24%, the highest since March 2020.

Covid AY.4.2 variant frequency too low to be of concern, says latest INSACOG bulletin

PTI -
In its weekly bulletin, Indian SARS-CoV-2 Genomics Consortium says the vaccine effectiveness does not seem to be different for AY.4.2 when compared to other Delta variants.

Modi govt places purchase order for 1 crore doses of ZyCov-D vaccine

PTI -
ZyCoV-D is the first needle-free Covid vaccine cleared by India’s drug regulator for inoculation of those aged 12 years and above.

Inquiry committee formed to probe Ahmednagar hospital fire that killed 11 Covid patients

PTI -
Speaking to the media, Union minister Bharati Pawar said action will be taken against the guilty. The fire broke out Saturday in the ICU unit of a hospital in Ahmednagar, Maharashtra.

UK reduces booking time for Covid booster shots by a month to ramp up vaccine rollout

Aditi Khanna -
All aged above 50 years and those at most risk from Covid will be able to book their appointment after five months rather than waiting for six months.

Your unvaccinated friend is 20 times more likely to give you Covid

Christopher Baker -
Dining in an all-vaccinated restaurant and working in an all-vaccinated workplace presents a much lower infection risk to us as individuals.
1...575859...1,000Page 58 of 1,000

On Camera

YourTurn

Opinion

What Modi govt’s Seeds Bill 2025 must deliver for Punjab’s farmers

K.B.S Sidhu -
The draft Seeds Bill gets the big ideas right: universal registration, traceability, real penalties. To work for Punjab, it must get federal plumbing and farmer-facing details sorted.

What Pakistan Supreme Court judge Mansoor Ali Shah wrote in his resignation letter

Modern lovers are trapped in ‘chalta hai’ relationships. Breakups are a lost art

Economy

As govt starts rolling back Quality Control Orders, a look at adverse impact they had, mainly on MSMEs

Udit Bubna -
Between 2016 and 2025, around 700 QCOs were issued by the government. Now, it has withdrawn 69 of them.

Defence

Drone manufacturer ideaForge wins orders worth over Rs 100 crore from Army

Snehesh Alex Philip -
ideaForge has formed a joint venture to manufacture and market UAVs in the US. Its Q6 UAV is now included in NATO and allied procurement systems.

National Interest

INDIA has a Congress-sized hole. And the fix begins with a little humility

Shekhar Gupta -
Without a Congress revival, there can be no challenge to the BJP pan-nationally. Modi’s party is growing, and almost entirely at the cost of the Congress.

Follow us

Copyright © 2025 Printline Media Pvt. Ltd. All rights reserved.